Phreesia, Inc. (NYSE: PHR) Stock Competitors & Peer Comparison
See PHR's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PHR and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PHR | $9.80 | -2.10% | 607M | 35.07 | $0.28 | N/A |
| VEEV | $179.58 | -2.69% | 29.2B | 21.57 | $8.33 | N/A |
| GEHC | $61.99 | +0.94% | 28.2B | 13.59 | $4.56 | +0.23% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $69.84 | +0.14% | 13.7B | 56.32 | $1.24 | N/A |
| BTSGU | $230.25 | +0.48% | 13.7B | 207.29 | $1.11 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| TEM | $46.01 | -2.02% | 8B | -92.02 | -$0.50 | N/A |
| HQY | $94.33 | -1.69% | 7.9B | 22.04 | $4.28 | N/A |
| TXG | $48.06 | +2.15% | 6.1B | -282.71 | -$0.17 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
PHR vs VEEV Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, VEEV has a market cap of 29.2B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while VEEV trades at $179.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas VEEV's P/E ratio is 21.57. In terms of profitability, PHR's ROE is +0.03%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, PHR is more volatile compared to VEEV. This indicates higher risk in terms of short-term price fluctuations for PHR.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
PHR vs GEHC Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, GEHC has a market cap of 28.2B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while GEHC trades at $61.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas GEHC's P/E ratio is 13.59. In terms of profitability, PHR's ROE is +0.03%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, PHR is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for PHR.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
PHR vs GEHCV Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas GEHCV's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, PHR is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for PHR.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
PHR vs BTSG Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, BTSG has a market cap of 13.7B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while BTSG trades at $69.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas BTSG's P/E ratio is 56.32. In terms of profitability, PHR's ROE is +0.03%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for PHR.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
PHR vs BTSGU Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, BTSGU has a market cap of 13.7B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while BTSGU trades at $230.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas BTSGU's P/E ratio is 207.29. In terms of profitability, PHR's ROE is +0.03%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for PHR.Check BTSGU's competition here
Signify Health, Inc. (NYSE: SGFY)
PHR vs SGFY Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas SGFY's P/E ratio is 70.91. In terms of profitability, PHR's ROE is +0.03%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, PHR is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SGFY's competition here
Tempus AI, Inc. (NASDAQ: TEM)
PHR vs TEM Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, TEM has a market cap of 8B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while TEM trades at $46.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas TEM's P/E ratio is -92.02. In terms of profitability, PHR's ROE is +0.03%, compared to TEM's ROE of -0.70%. Regarding short-term risk, PHR is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for PHR.Check TEM's competition here
HealthEquity, Inc. (NASDAQ: HQY)
PHR vs HQY Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, HQY has a market cap of 7.9B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while HQY trades at $94.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas HQY's P/E ratio is 22.04. In terms of profitability, PHR's ROE is +0.03%, compared to HQY's ROE of +0.11%. Regarding short-term risk, PHR is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for PHR.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
PHR vs TXG Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, TXG has a market cap of 6.1B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while TXG trades at $48.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas TXG's P/E ratio is -282.71. In terms of profitability, PHR's ROE is +0.03%, compared to TXG's ROE of -0.03%. Regarding short-term risk, PHR is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for PHR.Check TXG's competition here
R1 RCM Inc. (NASDAQ: RCM)
PHR vs RCM Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas RCM's P/E ratio is -102.21. In terms of profitability, PHR's ROE is +0.03%, compared to RCM's ROE of +0.00%. Regarding short-term risk, PHR is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for PHR.Check RCM's competition here
Hinge Health, Inc. (NYSE: HNGE)
PHR vs HNGE Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, HNGE has a market cap of 5.9B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while HNGE trades at $76.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas HNGE's P/E ratio is 39.26. In terms of profitability, PHR's ROE is +0.03%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, PHR is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for PHR.Check HNGE's competition here
Doximity, Inc. (NYSE: DOCS)
PHR vs DOCS Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, DOCS has a market cap of 3.8B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while DOCS trades at $20.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas DOCS's P/E ratio is 13.36. In terms of profitability, PHR's ROE is +0.03%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, PHR is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for PHR.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
PHR vs ONEM Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas ONEM's P/E ratio is -7.77. In terms of profitability, PHR's ROE is +0.03%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, PHR is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for PHR.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
PHR vs PRVA Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, PRVA has a market cap of 3.1B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while PRVA trades at $24.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas PRVA's P/E ratio is 156.06. In terms of profitability, PHR's ROE is +0.03%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, PHR is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for PHR.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
PHR vs PGNY Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, PGNY has a market cap of 2.4B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while PGNY trades at $30.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas PGNY's P/E ratio is 22.41. In terms of profitability, PHR's ROE is +0.03%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, PHR is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for PHR.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
PHR vs HTFL Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, HTFL has a market cap of 2.1B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while HTFL trades at $24.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas HTFL's P/E ratio is -12.24. In terms of profitability, PHR's ROE is +0.03%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, PHR is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for PHR.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
PHR vs WGS Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while WGS trades at $63.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas WGS's P/E ratio is 74.56. In terms of profitability, PHR's ROE is +0.03%, compared to WGS's ROE of -0.28%. Regarding short-term risk, PHR is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for PHR.Check WGS's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
PHR vs NXGN Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas NXGN's P/E ratio is -266.00. In terms of profitability, PHR's ROE is +0.03%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, PHR is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for PHR.Check NXGN's competition here
Teladoc Health, Inc. (NYSE: TDOC)
PHR vs TDOC Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, TDOC has a market cap of 1.6B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while TDOC trades at $8.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas TDOC's P/E ratio is -9.62. In terms of profitability, PHR's ROE is +0.03%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, PHR is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for PHR.Check TDOC's competition here
Agiliti, Inc. (NYSE: AGTI)
PHR vs AGTI Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas AGTI's P/E ratio is -71.79. In terms of profitability, PHR's ROE is +0.03%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, PHR is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for PHR.Check AGTI's competition here
Omada Health (NASDAQ: OMDA)
PHR vs OMDA Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, OMDA has a market cap of 1.3B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while OMDA trades at $21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas OMDA's P/E ratio is 302.86. In terms of profitability, PHR's ROE is +0.03%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, PHR is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for PHR.Check OMDA's competition here
Certara, Inc. (NASDAQ: CERT)
PHR vs CERT Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while CERT trades at $7.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas CERT's P/E ratio is 18.23. In terms of profitability, PHR's ROE is +0.03%, compared to CERT's ROE of -0.01%. Regarding short-term risk, PHR is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
PHR vs GDRX Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, GDRX has a market cap of 994.8M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while GDRX trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas GDRX's P/E ratio is 8.70. In terms of profitability, PHR's ROE is +0.03%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, PHR is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check GDRX's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
PHR vs CCLDO Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas CCLDO's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
PHR vs HSTM Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, HSTM has a market cap of 771M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while HSTM trades at $26.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas HSTM's P/E ratio is 34.72. In terms of profitability, PHR's ROE is +0.03%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, PHR is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for PHR.Check HSTM's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
PHR vs MPLN-WT Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, PHR is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
PHR vs ACCD Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas ACCD's P/E ratio is -3.08. In terms of profitability, PHR's ROE is +0.03%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, PHR is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for PHR.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
PHR vs SHCR Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas SHCR's P/E ratio is -3.76. In terms of profitability, PHR's ROE is +0.03%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, PHR is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
PHR vs EVH Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, EVH has a market cap of 519.7M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while EVH trades at $4.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas EVH's P/E ratio is 462.00. In terms of profitability, PHR's ROE is +0.03%, compared to EVH's ROE of -0.78%. Regarding short-term risk, PHR is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for PHR.Check EVH's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
PHR vs WGSWW Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, WGSWW has a market cap of 514.5M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas WGSWW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, PHR is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check WGSWW's competition here
NRC Health (NASDAQ: NRC)
PHR vs NRC Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, NRC has a market cap of 469.4M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while NRC trades at $20.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas NRC's P/E ratio is 25.40. In terms of profitability, PHR's ROE is +0.03%, compared to NRC's ROE of +0.57%. Regarding short-term risk, PHR is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for PHR.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
PHR vs SOPH Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, SOPH has a market cap of 415.9M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while SOPH trades at $6.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas SOPH's P/E ratio is -11.63. In terms of profitability, PHR's ROE is +0.03%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, PHR is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
PHR vs SLGCW Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, PHR's ROE is +0.03%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, PHR is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
PHR vs SLGC Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas SLGC's P/E ratio is -3.04. In terms of profitability, PHR's ROE is +0.03%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, PHR is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SLGC's competition here
Claritev Corporation (NYSE: CTEV)
PHR vs CTEV Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, CTEV has a market cap of 396.2M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while CTEV trades at $23.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas CTEV's P/E ratio is -1.78. In terms of profitability, PHR's ROE is +0.03%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, PHR is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for PHR.Check CTEV's competition here
TruBridge, Inc. (NASDAQ: TBRG)
PHR vs TBRG Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas TBRG's P/E ratio is 9.37. In terms of profitability, PHR's ROE is +0.03%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, PHR is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for PHR.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
PHR vs MPLN Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas MPLN's P/E ratio is -0.23. In terms of profitability, PHR's ROE is +0.03%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, PHR is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
PHR vs SLP Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, SLP has a market cap of 370.7M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while SLP trades at $18.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas SLP's P/E ratio is 20.83. In terms of profitability, PHR's ROE is +0.03%, compared to SLP's ROE of +0.06%. Regarding short-term risk, PHR is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
PHR vs TRHC Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas TRHC's P/E ratio is -4.27. In terms of profitability, PHR's ROE is +0.03%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, PHR is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for PHR.Check TRHC's competition here
So-Young International Inc. (NASDAQ: SY)
PHR vs SY Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, SY has a market cap of 251.9M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while SY trades at $1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas SY's P/E ratio is -5.82. In terms of profitability, PHR's ROE is +0.03%, compared to SY's ROE of -0.16%. Regarding short-term risk, PHR is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SY's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
PHR vs SMFR Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas SMFR's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, PHR is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
PHR vs SPOK Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, SPOK has a market cap of 219.5M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while SPOK trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas SPOK's P/E ratio is 17.52. In terms of profitability, PHR's ROE is +0.03%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, PHR is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
PHR vs AMWL Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, AMWL has a market cap of 181.1M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while AMWL trades at $10.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas AMWL's P/E ratio is -2.09. In terms of profitability, PHR's ROE is +0.03%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, PHR is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for PHR.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
PHR vs HCAT Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, HCAT has a market cap of 148.5M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while HCAT trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas HCAT's P/E ratio is 10.05. In terms of profitability, PHR's ROE is +0.03%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, PHR is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for PHR.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
PHR vs CPSI Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas CPSI's P/E ratio is -183.80. In terms of profitability, PHR's ROE is +0.03%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, PHR is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for PHR.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
PHR vs OPRX Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, OPRX has a market cap of 116.5M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while OPRX trades at $6.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas OPRX's P/E ratio is 5.70. In terms of profitability, PHR's ROE is +0.03%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, PHR is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
PHR vs AUGX Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas AUGX's P/E ratio is -4.99. In terms of profitability, PHR's ROE is +0.03%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, PHR is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
PHR vs CCLD Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, CCLD has a market cap of 92.2M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while CCLD trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas CCLD's P/E ratio is 8.04. In terms of profitability, PHR's ROE is +0.03%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
PHR vs DH Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, DH has a market cap of 72.4M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while DH trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas DH's P/E ratio is 2.64. In terms of profitability, PHR's ROE is +0.03%, compared to DH's ROE of -0.67%. Regarding short-term risk, PHR is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for PHR.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
PHR vs FORA Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas FORA's P/E ratio is -24.11. In terms of profitability, PHR's ROE is +0.03%, compared to FORA's ROE of -0.17%. Regarding short-term risk, PHR is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for PHR.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
PHR vs CCLDP Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas CCLDP's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
PHR vs SNCE Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas SNCE's P/E ratio is -0.27. In terms of profitability, PHR's ROE is +0.03%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, PHR is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SNCE's competition here
OneMedNet Corporation (NASDAQ: ONMD)
PHR vs ONMD Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, ONMD has a market cap of 34.3M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while ONMD trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas ONMD's P/E ratio is -4.01. In terms of profitability, PHR's ROE is +0.03%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, PHR is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for PHR.Check ONMD's competition here
Akili, Inc. (NASDAQ: AKLI)
PHR vs AKLI Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas AKLI's P/E ratio is -0.71. In terms of profitability, PHR's ROE is +0.03%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, PHR is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for PHR.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
PHR vs SHLT Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas SHLT's P/E ratio is -3.87. In terms of profitability, PHR's ROE is +0.03%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, PHR is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
PHR vs SHCRW Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, PHR's ROE is +0.03%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, PHR is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
PHR vs ONMDW Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, ONMDW has a market cap of 27.7M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas ONMDW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, PHR is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check ONMDW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
PHR vs EUDA Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, EUDA has a market cap of 26.9M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while EUDA trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas EUDA's P/E ratio is -27.17. In terms of profitability, PHR's ROE is +0.03%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, PHR is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for PHR.Check EUDA's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
PHR vs STRM Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas STRM's P/E ratio is -2.40. In terms of profitability, PHR's ROE is +0.03%, compared to STRM's ROE of -0.32%. Regarding short-term risk, PHR is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for PHR.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
PHR vs RNLX Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas RNLX's P/E ratio is -0.33. In terms of profitability, PHR's ROE is +0.03%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, PHR is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for PHR.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
PHR vs LIFW Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas LIFW's P/E ratio is -0.02. In terms of profitability, PHR's ROE is +0.03%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, PHR is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check LIFW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
PHR vs BEATW Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, BEATW has a market cap of 20.9M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas BEATW's P/E ratio is -0.06. In terms of profitability, PHR's ROE is +0.03%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, PHR is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check BEATW's competition here
Babylon Holdings Limited (NYSE: BBLN)
PHR vs BBLN Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas BBLN's P/E ratio is -0.04. In terms of profitability, PHR's ROE is +0.03%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, PHR is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for PHR.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
PHR vs ETAO Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas ETAO's P/E ratio is -0.01. In terms of profitability, PHR's ROE is +0.03%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, PHR is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for PHR.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
PHR vs BFRG Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, BFRG has a market cap of 7M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while BFRG trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas BFRG's P/E ratio is -1.11. In terms of profitability, PHR's ROE is +0.03%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, PHR is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for PHR.Check BFRG's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
PHR vs SCNX Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, SCNX has a market cap of 6M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while SCNX trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas SCNX's P/E ratio is -0.16. In terms of profitability, PHR's ROE is +0.03%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, PHR is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SCNX's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
PHR vs MGRX Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, MGRX has a market cap of 5.6M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while MGRX trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas MGRX's P/E ratio is -0.41. In terms of profitability, PHR's ROE is +0.03%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, PHR is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH)
PHR vs UPH Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas UPH's P/E ratio is -0.07. In terms of profitability, PHR's ROE is +0.03%, compared to UPH's ROE of -1.05%. Regarding short-term risk, PHR is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for PHR.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
PHR vs UPH-WT Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, PHR is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for PHR.Check UPH-WT's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
PHR vs PEAR Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas PEAR's P/E ratio is -0.08. In terms of profitability, PHR's ROE is +0.03%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, PHR is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for PHR.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
PHR vs PEARW Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas PEARW's P/E ratio is -0.00. In terms of profitability, PHR's ROE is +0.03%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, PHR is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
PHR vs OTRK Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas OTRK's P/E ratio is -0.02. In terms of profitability, PHR's ROE is +0.03%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, PHR is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for PHR.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
PHR vs HCTI Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while HCTI trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas HCTI's P/E ratio is -0.22. In terms of profitability, PHR's ROE is +0.03%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, PHR is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for PHR.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
PHR vs CMAX Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas CMAX's P/E ratio is -0.00. In terms of profitability, PHR's ROE is +0.03%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, PHR is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
PHR vs VSEE Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, VSEE has a market cap of 1.3M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while VSEE trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas VSEE's P/E ratio is -0.16. In terms of profitability, PHR's ROE is +0.03%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, PHR is more volatile compared to VSEE. This indicates higher risk in terms of short-term price fluctuations for PHR.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
PHR vs ACON Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while ACON trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas ACON's P/E ratio is -0.23. In terms of profitability, PHR's ROE is +0.03%, compared to ACON's ROE of -0.54%. Regarding short-term risk, PHR is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for PHR.Check ACON's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
PHR vs VSEEW Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, VSEEW has a market cap of 1.3M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, PHR's ROE is +0.03%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, PHR is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
PHR vs LIFWZ Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, PHR is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for PHR.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
PHR vs EUDAW Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, PHR's ROE is +0.03%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, PHR is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
PHR vs WORX Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, WORX has a market cap of 586.8K. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while WORX trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas WORX's P/E ratio is -0.64. In terms of profitability, PHR's ROE is +0.03%, compared to WORX's ROE of -0.65%. Regarding short-term risk, PHR is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for PHR.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
PHR vs MSPRZ Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, PHR is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERNW)
PHR vs KERNW Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas KERNW's P/E ratio is -0.00. In terms of profitability, PHR's ROE is +0.03%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, PHR is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
PHR vs KERN Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas KERN's P/E ratio is -0.01. In terms of profitability, PHR's ROE is +0.03%, compared to KERN's ROE of -0.17%. Regarding short-term risk, PHR is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for PHR.Check KERN's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
PHR vs ZCMD Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, ZCMD has a market cap of 60.1K. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while ZCMD trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas ZCMD's P/E ratio is -0.06. In terms of profitability, PHR's ROE is +0.03%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, PHR is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for PHR.Check ZCMD's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
PHR vs LIFWW Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas LIFWW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, PHR is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
PHR vs CMAXW Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas CMAXW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, PHR is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
PHR vs ACONW Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, ACONW has a market cap of 11.9K. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas ACONW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, PHR is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check ACONW's competition here
Cerner Corporation (NASDAQ: CERN)
PHR vs CERN Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, CERN has a market cap of 0. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas CERN's P/E ratio is 55.84. In terms of profitability, PHR's ROE is +0.03%, compared to CERN's ROE of +0.14%. Regarding short-term risk, PHR is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CERN's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
PHR vs AFFX Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas AFFX's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, PHR is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check AFFX's competition here
NantHealth, Inc. (NASDAQ: NH)
PHR vs NH Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, NH has a market cap of 0. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas NH's P/E ratio is -0.12. In terms of profitability, PHR's ROE is +0.03%, compared to NH's ROE of +0.35%. Regarding short-term risk, PHR is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for PHR.Check NH's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
PHR vs SMFRW Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas SMFRW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to SMFRW's ROE of -0.28%. Regarding short-term risk, PHR is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SMFRW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
PHR vs MTBCO Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas MTBCO's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for PHR.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
PHR vs MSPRV Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas MSPRV's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MSPRV's ROE of N/A. Regarding short-term risk, PHR is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MSPRV's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
PHR vs NAVA Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas NAVA's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, PHR is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for PHR.Check NAVA's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
PHR vs MTBCP Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas MTBCP's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for PHR.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
PHR vs MTBC Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas MTBC's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, PHR is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
PHR vs CHNG Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas CHNG's P/E ratio is -152.72. In terms of profitability, PHR's ROE is +0.03%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, PHR is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
PHR vs CHNGU Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas CHNGU's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, PHR is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CHNGU's competition here
Cue Health Inc. (NASDAQ: HLTH)
PHR vs HLTH Comparison July 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 607M. In comparison, HLTH has a market cap of 0. Regarding current trading prices, PHR is priced at $9.80 on the NYSE, while HLTH trades at $25.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.07, whereas HLTH's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to HLTH's ROE of +0.00%. Regarding short-term risk, PHR is more volatile compared to HLTH. This indicates higher risk in terms of short-term price fluctuations for PHR.Check HLTH's competition here